Bimiralisib, topical [PQR309] (panPI3K/mTOR)

Indicaton

Non-melanoma skin cancers and rare genetic skin manifestations.

Therapeutic indications

Type of product

Small molecule

Table

Phase

Discovery
Partnering status

Not partnered

You may also be interested in

nizubaglustat

Has the potential to treat multiple rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses, and Niemann-Pick disease type C (NPC).

Phase II started

AUP-16 (AUP1602-C)

AUP-16 is a multi-therapy live bacterial vector for chronic wounds: Diabetic Foot, Leg & Pressure Ulcers

Phase II started

Siklos (hydroxyurea)

Siklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome

Filing